JPS601164A - Optically active tryptophan salt crystal and its preparation - Google Patents
Optically active tryptophan salt crystal and its preparationInfo
- Publication number
- JPS601164A JPS601164A JP10727083A JP10727083A JPS601164A JP S601164 A JPS601164 A JP S601164A JP 10727083 A JP10727083 A JP 10727083A JP 10727083 A JP10727083 A JP 10727083A JP S601164 A JPS601164 A JP S601164A
- Authority
- JP
- Japan
- Prior art keywords
- tryptophan
- optically active
- crystal
- solution
- crystals
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Indole Compounds (AREA)
Abstract
Description
【発明の詳細な説明】
5水和物結晶及び光学活性トリプトファンを含有する溶
液からアルカリ性下N&イオンの存在下に光学活性トリ
プトファンlナトリウム5水和物結晶を取得する方法に
関するものである。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for obtaining optically active tryptophan l-sodium pentahydrate crystals from a solution containing pentahydrate crystals and optically active tryptophan under alkaline conditions and in the presence of N and ions.
トリプトファンは必須アミノ酸の一つでsb、人体又は
家畜の栄養源として有用である。これらに用いるトリプ
トファンは品質のよシ高いものが要望されている。Tryptophan is one of the essential amino acids and is useful as a nutritional source for the human body or livestock. The tryptophan used in these products is required to be of high quality.
トリプトファンの製造法としては化学合成法、酵素法、
発酵法等が行われている。これらの製造過程におけるト
リプトファンの分離精製法としては、金属塩を添加して
ラセミ体の複塩を形成する方法(特公昭5 0 − 1
1 9 1 4)、陰イオンおよび陽イオン交換樹脂
を用いる方法(特開昭53−111061)、或いは吸
着樹脂と限外濾過膜を組合せた方法(特開昭58−89
5 )等がある。Methods for producing tryptophan include chemical synthesis method, enzymatic method,
Fermentation methods are being used. As a method for separating and purifying tryptophan in these manufacturing processes, a method of adding a metal salt to form a racemic double salt (Japanese Patent Publication No. 50-1
1 9 1 4), a method using an anion and cation exchange resin (Japanese Patent Laid-Open No. 53-111061), or a method combining an adsorption resin and an ultrafiltration membrane (Japanese Patent Laid-Open No. 58-89)
5) etc.
しかしながら、光学活性トリプトファンは着色物質等と
共に樹脂に吸、脱着する傾向が強いので、その分離精製
には複雑な工程及び操作が必要とされる。また晶析中に
着色物質等が結晶に吸着、混入しやすい。そのためにア
ルコールなどの有機溶を用いて晶析する方法もあるが溶
媒の回収など工程が煩雑になる。However, since optically active tryptophan has a strong tendency to adsorb to and desorb from resin together with colored substances, complicated steps and operations are required for its separation and purification. Additionally, colored substances are easily adsorbed and mixed into the crystals during crystallization. For this purpose, there is a method of crystallization using an organic solvent such as alcohol, but this requires complicated steps such as recovering the solvent.
このようにトリプトファンの吸着親和性が大なるために
、容易に着色物質等の不純物を除去する手段は知られて
いない。Because tryptophan has such a high adsorption affinity, there is no known means for easily removing impurities such as colored substances.
本発明者らは、晶析によって不純物の効果的除去をなす
べく鋭意検討した結果、光学活性トリプトファンをナト
リウム塩として晶析することによって、極めて容易に不
純物が除去されることを発見した。The present inventors have made extensive studies to effectively remove impurities by crystallization, and have discovered that impurities can be removed extremely easily by crystallizing optically active tryptophan as a sodium salt.
すなわち、光学活性トリプトファンを含む溶液にアルカ
リ仕丁Naイオンを存在させると光学活性トリブトファ
ン1ナトリウム5水和物結晶が析出する。この結晶は着
色物質等の不純物との吸着親和性が極めて小さく、シか
も液性はアルカリ性であるために不純物は溶解し易く母
液へ抜くことができる。That is, when alkaline Na ions are present in a solution containing optically active tryptophan, optically active tributophane monosodium pentahydrate crystals are precipitated. These crystals have extremely low adsorption affinity for impurities such as colored substances, and since the liquid is alkaline, impurities are easily dissolved and can be extracted into the mother liquor.
光学活性トリプトファン1ナトリウム5水和物結晶の物
性は以下の通シである。因みに物性測定に用いた結晶は
実施例1に示した方法によって得られたものである。The physical properties of optically active tryptophan monosodium pentahydrate crystals are as follows. Incidentally, the crystals used for measuring the physical properties were obtained by the method shown in Example 1.
(1ン 元素分析:表1の通シ
0 58.41% 57.70チ
H4,904,78
N 12.38 12.25
0 14.15 14.53
Na 10.16 10.74
H2028,4828,82
(2)融点=45℃で流動化、55℃で融解開始、70
℃で完全融解。(1 elemental analysis: Table 1 0 58.41% 57.70 H4,904,78 N 12.38 12.25 0 14.15 14.53 Na 10.16 10.74 H2028,4828, 82 (2) Melting point = Fluidization at 45°C, melting start at 55°C, 70
Completely thawed at °C.
(3)示差熱分析:昇温2に/miH,45℃〜300
℃で測定。(3) Differential thermal analysis: temperature increase 2/miH, 45℃~300
Measured in °C.
46℃〜78℃ 3H20離脱 吸熱反応 □78℃〜
114℃ 2H20離脱(無水化) 吸熱反応226℃
〜 分解開始(炭化) 発熱反応(4)比旋光度:〔α
) −+3.5(C=2.H2O)(5)X線回折:C
u−Ka−X線による粉末X線回折ノ4ターンは、次の
位置(2θ(至))に強いピークが見られた。4.1,
10.8,11.9,15.9,16.2,27.1お
よび32.6゜
(6)溶媒に対する溶解性:水、エタノールに易溶、ア
セトンに難溶。46℃〜78℃ 3H20 withdrawal Endothermic reaction □78℃〜
114℃ 2H20 separation (anhydration) Endothermic reaction 226℃
~ Start of decomposition (carbonization) Exothermic reaction (4) Specific optical rotation: [α
) −+3.5 (C=2.H2O) (5) X-ray diffraction: C
Four turns of powder X-ray diffraction using u-Ka-X rays showed a strong peak at the following position (2θ). 4.1,
10.8, 11.9, 15.9, 16.2, 27.1 and 32.6° (6) Solubility in solvents: Easily soluble in water and ethanol, poorly soluble in acetone.
(7)呈色反応:ニンヒドリン反応は赤紫色。(7) Color reaction: Ninhydrin reaction produces a reddish-purple color.
(8)水溶液の液性:強アルカリ性。(8) Liquidity of aqueous solution: strongly alkaline.
(9)結晶形:板状晶。ただし、晶析方法、溶液状態に
よって柱状に近くなることもあシ、厚みも変化する。(9) Crystal form: plate crystal. However, depending on the crystallization method and solution state, it may become almost columnar, and the thickness may also vary.
因みに、本発明のトリプトファン塩結晶は、既知の遊離
のトリットファン結晶に較べて晶癖がよく、高純度に得
られるので、例えば、着色のあるトリプトファン結晶の
精製に本発明の方法が使用され得るし、また、本発明の
トリプトファン塩結晶は単なる中和によって高純度の光
学活性トリプトファン結晶とすることもできる。Incidentally, the tryptophan salt crystals of the present invention have a better crystal habit and can be obtained with higher purity than known free tryptophan crystals, so the method of the present invention can be used, for example, to purify colored tryptophan crystals. However, the tryptophan salt crystals of the present invention can also be made into highly pure optically active tryptophan crystals by simple neutralization.
このような光学活性トリプトファン1ナトリウム5水和
物結晶はpH10,9以上で析出する。Naイオンの量
は、溶液中のトリプトファンに対するNaイオンのモル
比として1以上、好ましくは2〜5程度がよい。これ以
上加えても、結晶取得量はあまシ増えないので、アルカ
リの浪費となル得策でない・
Naイオン源および一調節剤としては、通常NaOHが
用いられるが、NaCt*Na2SO4を酢酸ナトリウ
ムなどのNa塩とKOH,LiOH,NH4OHなどの
アルカリを併用してもよい。またNaOHを使用すると
きでも、NaOHの量が多いほど晶析率は高いので、N
aOHを少くした場合NaC2,Na 2 So 4な
どの塩類を共存させてNaイオンの共通イオン効果によ
シ晶析率を上げることもできる。Such optically active tryptophan monosodium pentahydrate crystals precipitate at pH 10.9 or higher. The amount of Na ions is preferably 1 or more, preferably about 2 to 5 as a molar ratio of Na ions to tryptophan in the solution. Even if more than this is added, the amount of crystals obtained will not increase significantly, so it is a waste of alkali and is not a good idea. NaOH is usually used as the Na ion source and regulator, but NaCt*Na2SO4 can be mixed with sodium acetate etc. Na salt and an alkali such as KOH, LiOH or NH4OH may be used in combination. Also, even when using NaOH, the higher the amount of NaOH, the higher the crystallization rate, so N
When the amount of aOH is reduced, it is also possible to increase the crystallization rate by coexisting salts such as NaC2 and Na2So4 due to the common ion effect of Na ions.
晶析は冷却晶析によるのが好都合である。たとえば、溶
液を30〜50℃付近から徐冷しながら飽和濃度に達し
たら必要によシ種晶を加えて更に冷却し、0°〜30℃
付近で分離する。この結晶は室温において風乾すると脱
水して無水物に変シ易い。Conveniently, the crystallization is by cooling crystallization. For example, slowly cool the solution from around 30 to 50°C, and when it reaches the saturation concentration, add seed crystals as necessary and cool it further to 0° to 30°C.
Separate nearby. When this crystal is air-dried at room temperature, it easily dehydrates and transforms into an anhydride.
本発明の結晶は、光学活性トリプトファンを含有する水
溶液から広く晶析させることができるが、特に着色物質
を含む発酵液、−酵素反応液由来の不鈍物を除去する効
果が大きい。このような液の例として、発酵液及び酵素
反応液、又はその除菌液、或いはそれらをイオン交換樹
脂、非イオン系樹脂、限外濾過、逆浸透濾過等で精製処
理した液、これらの液からトリシトファンを晶析分離し
た母液又はその結晶(粗結晶)の溶解液等を挙げること
ができる。又、DL体を光学分割した後の光学活性体の
晶析にも適用できる。The crystals of the present invention can be widely crystallized from aqueous solutions containing optically active tryptophan, and are particularly effective in removing dull substances derived from fermentation liquids and enzyme reaction liquids containing colored substances. Examples of such liquids include fermentation liquids, enzyme reaction liquids, sterilizing liquids thereof, liquids purified by using ion exchange resins, nonionic resins, ultrafiltration, reverse osmosis filtration, etc., and liquids such as these. For example, a mother liquor obtained by crystallizing and separating tricytophan from a liquid or a solution of its crystals (crude crystals) may be used. It can also be applied to crystallization of an optically active substance after optical resolution of the DL form.
分離した光学活性トリットファン1ナトリクム5水和物
結晶は、水に溶解して塩酸等の酸で中和晶析するこ・と
によって、光学活性トリシトファン結晶を得ることがで
きる。The separated optically active tricytophan monosodium pentahydrate crystals can be dissolved in water and neutralized and crystallized with an acid such as hydrochloric acid to obtain optically active tricytophan crystals.
以下実施例を示す。Examples are shown below.
実施例I
L−)リグドア7ン102.IJ7及びNa0I(50
1を水190ゴに40℃で溶解したのち、放冷しながら
19℃まで攪拌晶析した。Example I L-) Rig door 7n102. IJ7 and Na0I (50
After dissolving 1 in 190 g of water at 40°C, the solution was stirred and crystallized to 19°C while cooling.
20時間後に晶析スラリーを遠心分離して、結晶133
JFを得た。収率84.0’%。分析値は表1に示した
。After 20 hours, the crystallization slurry was centrifuged to obtain crystals 133.
I got JF. Yield 84.0'%. The analytical values are shown in Table 1.
実施例2
L−トリブトファン発酵液(特開昭56−92796)
を強酸性陽イオン交換樹脂に通してL−)リプドアアン
を吸着させたのち、2NNaOH溶液で溶離した。Example 2 L-tributophane fermentation liquid (Japanese Patent Application Laid-Open No. 56-92796)
was passed through a strongly acidic cation exchange resin to adsorb L-) lipoan, followed by elution with a 2N NaOH solution.
この溶離液を濃縮して、L−)リプドアアン27.4チ
、N”/L−)リグ)77ン(モ#比)=4.1、pH
約14の濃縮液を得た。The eluent was concentrated to give L-) lipoan 27.4 h, N''/L-) lig) 77 n (molar ratio) = 4.1, pH
Approximately 14 concentrates were obtained.
この濃縮液300#をとシ、20時間かけて10℃まで
冷却晶析した。300 # of this concentrated solution was collected and crystallized by cooling to 10° C. over 20 hours.
析出した結晶を遠心分離してトリプトファンナトリウム
塩結晶117gを得た。トリプトファン含量64.1%
、収率91.2%。この結晶の透過率は87%であった
( C= 1 、 HClでpH5,9に調整、430
nm)。The precipitated crystals were centrifuged to obtain 117 g of tryptophan sodium salt crystals. Tryptophan content 64.1%
, yield 91.2%. The transmittance of this crystal was 87% (C=1, pH adjusted to 5.9 with HCl, 430
nm).
比較例1
実施例2の濃縮液300IIをとシ、水で800ゴに稀
釈したのち、濃塩酸を添加してpH5,9まで中和晶析
した。Comparative Example 1 The concentrated solution 300 II of Example 2 was diluted with water to 800 g, and then concentrated hydrochloric acid was added to neutralize and crystallize the solution to pH 5.9.
析出した結晶を遠心分離して60℃、減圧乾燥した結晶
68.711を得た。トリプトファン含量98.6%、
収率82.4%。この結晶の透過率は43%でアった(
C=1、水、4301m)。The precipitated crystals were centrifuged and dried at 60°C under reduced pressure to obtain crystals 68.711. Tryptophan content 98.6%,
Yield 82.4%. The transmittance of this crystal was 43% (
C=1, water, 4301m).
実施例3
比較例1で得たトリシトファン結晶(粗結晶)209と
NaOH711を水4Qmlに40℃で溶解したのち、
5℃まで冷却晶析した。Example 3 After dissolving the tricytophan crystal (crude crystal) 209 obtained in Comparative Example 1 and NaOH711 in 4Qml of water at 40°C,
Crystallization was performed by cooling to 5°C.
スラリーを遠心分離してトリプトファンナトリウム塩結
晶28.5#を得た。トリプトファン含量6265%、
収率90.3%。この結晶の透過率は96%であった(
実施例2と同一条件で測定)。The slurry was centrifuged to obtain tryptophan sodium salt crystals 28.5#. Tryptophan content 6265%,
Yield 90.3%. The transmittance of this crystal was 96% (
Measured under the same conditions as Example 2).
比較例2
比較例1で得たトリプトファン結晶2019を濃塩酸8
.5−と水150m7に溶解し、P紙で濾過したPii
に30チNaOH溶液を添加してpH5,9まで中和晶
析した。Comparative Example 2 Tryptophan crystals 2019 obtained in Comparative Example 1 were dissolved in concentrated hydrochloric acid 8
.. 5- and Pii dissolved in 150 m7 of water and filtered through P paper.
A 30% NaOH solution was added to the solution to neutralize and crystallize it to pH 5.9.
析出した結晶を遠心分離して60℃、減圧乾燥した結晶
16.7.9を得た。トリプトファン含量99.1%、
収率83.9%、この結晶の透過率は58%であった(
比較例1と同一条件で測定)0実施例4
L−トリブトファン発酵液に35%HC1t−〆13ま
で加えて遠心分離した除菌液ILに30 %NaOH溶
液をpi−112,5まで加えて濃縮した。この濃縮液
110g()リプトファン含量15.4L)を40℃か
ら5℃まで25時間かけて冷却晶析した。The precipitated crystals were centrifuged and dried at 60°C under reduced pressure to obtain crystals 16.7.9. Tryptophan content 99.1%,
The yield was 83.9%, and the transmittance of this crystal was 58% (
Measured under the same conditions as Comparative Example 1) 0 Example 4 35% HC1t-13 was added to the L-tributophane fermentation solution and centrifuged. 30% NaOH solution was added to pi-112.5 and concentrated. did. 110 g of this concentrated solution (Lyptophan content: 15.4 L) was cooled and crystallized from 40° C. to 5° C. over 25 hours.
析出した結晶を遠心分離したのち、少量の冷水を噴霧し
て洗浄した。得られたトリプトファンナトリウム塩結晶
は22.5.9(トリプトファン含量60.8%、収率
80.7%)で、この結晶の透過率は82%であった。After the precipitated crystals were centrifuged, they were washed by spraying a small amount of cold water. The tryptophan sodium salt crystal obtained was 22.5.9 (tryptophan content 60.8%, yield 80.7%), and the transmittance of this crystal was 82%.
(実施例2と同一条件で測定)。(Measured under the same conditions as Example 2).
特許出願人 味の素株式会社Patent applicant: Ajinomoto Co., Inc.
Claims (2)
結晶(1) Optically active tryptophan monosodium pentahydrate crystal
,9以上でかつ溶液中のトリプトファンに対するNaイ
オンのモル比が1以上である量のNaイオンの存在下に
晶析操作に付することを特徴とする光学活性トリットフ
ァン1ナトリパウム5水和物結晶の製造方法。(2) An aqueous solution containing optically active tryptophan at -10
, 9 or more and the crystallization operation is performed in the presence of Na ions in an amount such that the molar ratio of Na ions to tryptophan in the solution is 1 or more. manufacturing method.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10727083A JPS601164A (en) | 1983-06-15 | 1983-06-15 | Optically active tryptophan salt crystal and its preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10727083A JPS601164A (en) | 1983-06-15 | 1983-06-15 | Optically active tryptophan salt crystal and its preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS601164A true JPS601164A (en) | 1985-01-07 |
Family
ID=14454800
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP10727083A Pending JPS601164A (en) | 1983-06-15 | 1983-06-15 | Optically active tryptophan salt crystal and its preparation |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS601164A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008098355A1 (en) * | 2007-02-16 | 2008-08-21 | Apotex Technologies Inc. | Crystalline forms of the mono-sodium salt of d-isoglutamyl-d-tryptophan |
-
1983
- 1983-06-15 JP JP10727083A patent/JPS601164A/en active Pending
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008098355A1 (en) * | 2007-02-16 | 2008-08-21 | Apotex Technologies Inc. | Crystalline forms of the mono-sodium salt of d-isoglutamyl-d-tryptophan |
US8481588B2 (en) | 2007-02-16 | 2013-07-09 | Apotex Technologies Inc. | Crystalline forms of the mono-sodium salt of D-isoglutamyl-D-tryptophan |
US8592607B2 (en) | 2007-02-16 | 2013-11-26 | Apotex Technologies Inc. | Crystalline forms of the mono-sodium salt of D-isoglutamyl-D-tryptophan |
US8664262B2 (en) | 2007-02-16 | 2014-03-04 | Apotex Technologies Inc. | Crystalline forms of the mono-sodium salt of D-isoglutamyl-D-tryptophan |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HU202282B (en) | Process for separating 2-keto-l-gulonic acid from fermentation juice | |
JP3694921B2 (en) | Purification method of valine | |
JP2893813B2 (en) | Crystallization of optically active tryptophan | |
CA1150308A (en) | L-phenylalanine 1/2 sulfate and its use | |
JPS601164A (en) | Optically active tryptophan salt crystal and its preparation | |
JPS5939857A (en) | Crystallization of amino acid | |
JPH0574583B2 (en) | ||
JPS6027394A (en) | Recovery of optically active tryptophan | |
JPH0352455B2 (en) | ||
JPS604168A (en) | Crystallization of tryptophan | |
JP2877366B2 (en) | Method for producing crystalline L-ascorbic acid-2-phosphate sodium salt | |
RU2779668C1 (en) | Method for producing calcobutrol | |
US2580195A (en) | Method of purifying 4-aminosalicylic acid | |
US4124636A (en) | Method of preparing monopotassium L-malate and its monohydrate | |
JPH0342269B2 (en) | ||
JPS6379888A (en) | Stable hydrate of penicillin derivative | |
JPH0342268B2 (en) | ||
US2444087A (en) | Process of recovering an ascorbic acid compound | |
JPS6032752A (en) | Production of optically active phenylalanine | |
JPH0267256A (en) | Isolation and purification of carnitine and carnitinenitrile | |
JPS6013746A (en) | Novel phenylalanine salt crystal and its preparation | |
JPS59128365A (en) | Novel phenylalanine salt crystal and its preparation | |
JPS5849540B2 (en) | Purification method of compound having both amino group and sulfonic acid group | |
US2626947A (en) | Decolorization of synthetic folic acid | |
JPH02172989A (en) | Production of high-purity cephalosporin derivative |